30 related articles for article (PubMed ID: 11402302)
1. Efficient and regulated erythropoietin production by naked DNA injection and muscle electroporation.
Rizzuto G; Cappelletti M; Maione D; Savino R; Lazzaro D; Costa P; Mathiesen I; Cortese R; Ciliberto G; Laufer R; La Monica N; Fattori E
Proc Natl Acad Sci U S A; 1999 May; 96(11):6417-22. PubMed ID: 10339602
[TBL] [Abstract][Full Text] [Related]
2. Induction of local immunosuppression in allogeneic cell transplantation by cell-type-specific expression of PD-L1 and CTLA4Ig.
Zhu W; Li M; Zou J; Zhang D; Fang M; Sun Y; Li C; Tang M; Wang Y; Zhou Q; Zhao T; Li W; Hu Z; Hu B
Stem Cell Reports; 2023 Dec; 18(12):2344-2355. PubMed ID: 37995700
[TBL] [Abstract][Full Text] [Related]
3. Immortalized human myoblast cell lines for the delivery of therapeutic proteins using encapsulated cell technology.
Lathuiliere A; Vernet R; Charrier E; Urwyler M; Von Rohr O; Belkouch MC; Saingier V; Bouvarel T; Guillarme D; Engel A; Salmon P; Laumonier T; Grogg J; Mach N
Mol Ther Methods Clin Dev; 2022 Sep; 26():441-458. PubMed ID: 36092361
[TBL] [Abstract][Full Text] [Related]
4. Continuous delivery of human and mouse erythropoietin in mice by genetically engineered polymer encapsulated myoblasts.
Régulier E; Schneider BL; Déglon N; Beuzard Y; Aebischer P
Gene Ther; 1998 Aug; 5(8):1014-22. PubMed ID: 10326023
[TBL] [Abstract][Full Text] [Related]
5. Immunomodulation of pancreatic islet allografts in mice with CTLA4Ig secreting muscle cells.
Chahine AA; Yu M; McKernan MM; Stoeckert C; Lau HT
Transplantation; 1995 May; 59(9):1313-8. PubMed ID: 7762068
[TBL] [Abstract][Full Text] [Related]
6. Blockade of CD40 pathway enhances the induction of immune tolerance by immature dendritic cells genetically modified to express cytotoxic T lymphocyte antigen 4 immunoglobulin.
Sun W; Wang Q; Zhang L; Liu Y; Zhang M; Wang C; Wang J; Cao X
Transplantation; 2003 Nov; 76(9):1351-9. PubMed ID: 14627915
[TBL] [Abstract][Full Text] [Related]
7. Local high-capacity adenovirus-mediated mCTLA4Ig and mCD40Ig expression prolongs recombinant gene expression in skeletal muscle.
Jiang ZL; Reay D; Kreppel F; Gambotto A; Feingold E; Kochanek S; McCarthy SA; Clemens PR
Mol Ther; 2001 Jun; 3(6):892-900. PubMed ID: 11407903
[TBL] [Abstract][Full Text] [Related]
8. Feasibility of CTLA4Ig gene delivery and expression in vivo using retrovirally transduced myeloid dendritic cells that induce alloantigen-specific T cell anergy in vitro.
Takayama T; Morelli AE; Robbins PD; Tahara H; Thomson AW
Gene Ther; 2000 Aug; 7(15):1265-73. PubMed ID: 10918497
[TBL] [Abstract][Full Text] [Related]
9. A self-immunomodulating myoblast cell line for erythropoietin delivery.
Schneider BL; Peduto G; Aebischer P
Gene Ther; 2001 Jan; 8(1):58-66. PubMed ID: 11402302
[TBL] [Abstract][Full Text] [Related]
10. [Transplantation of normal or genetically modified myoblasts for the treatment of hereditary or acquired diseases].
Tremblay JP; Vilquin JT
J Soc Biol; 2001; 195(1):29-37. PubMed ID: 11530497
[TBL] [Abstract][Full Text] [Related]
11. Gene transfer for erythropoiesis enhancement.
Naffakh N; Danos O
Mol Med Today; 1996 Aug; 2(8):343-8. PubMed ID: 8796920
[TBL] [Abstract][Full Text] [Related]
12. Epo delivery by genetically engineered C2C12 myoblasts immobilized in microcapsules.
Murua A; Orive G; Hernandez RM; Pedraz JL
Adv Exp Med Biol; 2010; 670():54-67. PubMed ID: 20384218
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
